LMNX - Defiance Daily Target 2X Long LMND ETF -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Defiance Daily Target 2X Long LMND ETF
Luminex Corp develops, manufactures and sells proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. Its products include MAGPIX, Luminex 100/200, and FLEXMAP 3D.
IPO Date: October 15, 2025
Sector: 2x Bull LMND
Industry: Medical Instruments & Equipment
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.58 | 6.92%
Avg Daily Range (30 D): $0.23 | 2.72%
Avg Daily Range (90 D): $0.71 | 5.29%
Institutional Daily Volume
Avg Daily Volume: .04M
Avg Daily Volume (30 D): .02M
Avg Daily Volume (90 D): .03M
Trade Size
Avg Trade Size (Sh.): 142
Avg Trade Size (Sh.) (30 D): 135
Avg Trade Size (Sh.) (90 D): 162
Institutional Trades
Total Institutional Trades: 0
Avg Institutional Trade: $M
Avg Institutional Trade (30 D): $M
Avg Institutional Trade (90 D): $M
Avg Institutional Trade Volume: M
Avg Institutional Trades (Per Day): 0
Market Closing Trades
Avg Closing Trade: $M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: K
 
News
Jun 20, 2021 @ 11:03 AM
Wall Street Breakfast: The Week Ahead
Source: Wall Street Breakfast
May 27, 2021 @ 2:30 PM
LHC Group (LHCG) Forays Into Oregon With New Acqui...
Source: Zacks Equity Research
May 14, 2021 @ 2:10 PM
PerkinElmer (PKI) Boosts Cell Biology Portfolio Wi...
Source: Zacks Equity Research
Financials
  TTM FY 2021 TTM
Basic EPS $.51
Diluted EPS $.51
Revenue $437.66M
Gross Profit $263.97M
Net Income / Loss $23.6M
Operating Income / Loss $54.26M
Cost of Revenue $173.69M
Net Cash Flow $228.48M
PE Ratio